5426502026-08-205426502026-08-202026-08-205426502026-08-202026-08-20UnitOrDivisionOrSubsidiaryDomain15426502026-08-20UnitOrDivisionOrSubsidiaryDomain1iso4217:INRxbrli:pure542650Metropolis Healthcare LimitedMETROPOLISNOTLISTEDINE112L01020NewSale or disposal of unit(s)/division(s)/subsidiaryfalse2026-08-2015:00:002026-08-20Note: The Date of Agreement for Sale is not applicable. However, for the purpose of validating the file, August 20, 2026 has been entered as the date.SubsidiaryMetropolis Quality Solutions Private Limited000000002026-08-202032-08-20OthersOffer and issuance of 10,000 OCRPS of face value of INR 10/- (Indian Rupees Ten only) each, at par, aggregating to INR 1,00,000/- (Indian Rupees One Lakh only).Dr. Puneet Kumar Nigam, former Chief Quality Officer of the Company, is the proposed allottee. He does not belong to the Promoter or Promoter Group of the Company.falsefalsetruefalseMetropolis Quality Solutions Private Limited (“MQSPL”), a wholly owned subsidiary of Metropolis Healthcare Limited (“the Company”), has today approved the offer and issuance of Optionally Convertible Redeemable Preference Shares (“OCRPS”). Upon successful subscription to and subsequent conversion of these OCRPS into equity shares, MQSPL will cease to be a wholly owned subsidiary of the Company but will continue to remain a subsidiary of the Company. 1) The amount and percentage of the turnover or revenue or income and net worth contributed by such unit or division or undertaking or subsidiary or associate company of the listed entity during the last financial year: Metropolis Quality Solutions Private Limited (‘MQSPL’) is a private limited company incorporated on September 15, 2025, under the Indian Companies Act, 2013. MQSPL is yet to commence its business operations and hence has not contributed to the turnover, revenue, income, or net worth of the Company. 2) The expected date of completion of sale/disposal: The conversion of Optionally Convertible Redeemable Preference Shares (“OCRPS”) into equity shares (at a ratio of 1:1) is subject to the fulfilment of the terms and conditions attached to the issuance and will be executed in tranches. The overall timeline for the complete conversion is expected to be up to 6 years.